December 1-7 is Crohn’s and Colitis Awareness Week. Known collectively as inflammatory bowel disease (IBD), Crohn’s disease and ulcerative colitis are painful, medically incurable diseases that impact the digestive system. Crohn’s disease may attack anywhere along the digestive tract, while ulcerative colitis inflames only the large intestine (colon).
There are more than 10 million people worldwide living with IBD. While it is not a life-threatening disease in the majority of cases, it has a significant impact on the quality of life and most people will require surgery at least once in their lifetime.
Symptoms for both diseases may include diarrhea, rectal bleeding, abdominal pain, fatigue and weight loss.
There is no cure for Crohn’s disease, nor for ulcerative colitis, but therapies can greatly reduce the signs and symptoms and even bring about long-term remission and healing of inflammation.
GCT is proud to be a part of ulcerative colitis and Crohn’s disease clinical research and drug development. For more information about our experience, please contact us at bd@gctrials.com.